Hossein Tabriziani MD FACP , FASN
Kidney & Pancreas Transplantation
Transplant Nephrologist
Join to view full profile
HossMed, IncSan Diego, CA 92101
Dr. Tabriziani is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco) School of MedicineFellowship, Transplsnt, 2012 - 2013
MedStar Health Georgetown UniversityFellowship, Nephrology, 2010 - 2012
St Barnabas HospitalResidency, Internal Medicine, 1999 - 2002
Iran University of Medical SciencesClass of 1995
Certifications & Licensure
CA State Medical License 2002 - 2027
IL State Medical License 2020 - 2023
DC State Medical License 2010 - 2018
NY State Medical License 2009 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013, 2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2017
- FASN ASN , American Society of Nephrology, 2015
Publications & Presentations
PubMed
- Donor-derived Cell-free DNA for Detection of Rejection After Pancreas Transplantation.Abraham J Matar, Samy Riad, Heidi Sarumi, Michael G Megaly, Matthew Wright
Transplantation Direct. 2026-05-01 - Genetic Testing in the Management of Adult CKD.Fouad T Chebib, Xiangling Wang, Suneel M Udani, Maggie Westemeyer, Dinah Clark
Journal of the American Society of Nephrology. 2026-04-01 - Response to comment on: Associations between donor-derived cell-free DNA dynamics and clinical outcomes after kidney allograft rejection: A prospective, multicenter st...Suphamai Bunnapradist, Hossein Tabriziani, Yasir Qazi
American Journal of Transplantation. 2026-04-01
Press Mentions
PEDAL Study Successful, Shows Monitoring with Prospera™ Kidney Provides Accurate Prognosis of Long-Term Clinical Outcomes Following Rejection; Now Published in AJTJuly 24th, 2025- Natera Announces Definitive Study to Evaluate the Clinical Utility of Renasight in the Diagnosis and Management of Chronic Kidney Disease (CKD)April 28th, 2022
- Natera Announces New Prospera™ Data at the ATC 2021 Virtual Connect ConferenceJune 4th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
